Abifadel M,Varret M,Rabes JP,Allard D,Ouguerram K,Devillers M,Boileau C M .2003 .Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet, 34(2) : 154-156.
Celermajer DS,Chow CK,Marijon E,Anstey NM,Woo KS .2012 .Cardiovascular disease in the developing world: Prevalences, patterns and the potential of early disease detection. J. Am. Coll. Cardiol, 60(14) : 1207-1216.
Chasman DI,Pare G,Mora S,Hopewell JC,Peloso G,Clarke R,Ridker PM .2009 .Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet, 5(11) : e1000730.
Chasman DI,Posada D,Subrahmanyan L,Cook NR,Ridker PM .2004 .Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA., 291(23) : 2821-2827.
Christidis DS,Liberopoulos EN,Kakafika AI,Miltiadous GA,Cariolou M,Ganotakis ES,Elisaf MS .2006 .The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate. JCPT, 11(3) : 211-221.
Deo RC,Reich D,Tandon A,Akylbekova E,Patterson N,Waliszewska A,Wilson JG .2009 .Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: The Jackson Heart Study. PLoS Genet, 5(1) : e1000342.
Deshmukh HA,Colhoun HM,Johnson T,McKeigue PM,Betteridge DJ,Durrington PN,Hitman GA .2012 .Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: Importance of Lp (a). J. Lipid Res., 53(5) : 1000-1011.
Fiegenbaum M,da Silveira FR,Van der Sand CR,Van der Sand LC,Ferreira ME,Pires RC,Hutz MH .2005 .Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects. Clin. Chim. Acta., 362(1-2) : 182-188.
Ilveskoski E,Loimaala A,Mercuri MF,Lehtimäki T,Pasanen M,Nenonen A,Vuori I .2000 .Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middleaged men. Atherosclerosis, 153(1) : 147-153.
Inouye M,Ripatti S,Kettunen J,Lyytikainen LP,Oksala N,Laurila PP,De Bakker PI PP .2012 .Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet, 8(8) : e1002907.
Kathiresan S,Melander O,Guiducci C,Surti A,Burtt NP,Rieder MJ,Orho-Melander M .2008 .Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet, 40(2) : 189-197.
Kim YJ,Go MJ,Hu C,Hong CB,Kim YK,Lee JY,Cho YS .2011 .Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat. Genet, 43(10) : 990.
Kooner JS,Chambers JC,Aguilar-Salinas CA,Hinds DA,Hyde CL,Warnes GR,Thompson JF GR .2008 .Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat. Genet, 40(2) : 149.
Krauss RM,Mangravite LM,Smith JD,Medina MW,Wang D,Guo X,Rotter JI .2008 .Clinical perspective. Circulation, 117(12) : 1537-1544.
Lehtimäki T,Moilanen T,Nikkari T,Solakivi T,Porkka K,Ehnholm C,Viikari J .1991 .Regional differences in apolipoprotein E polymorphism in Finland. , 23(1) : 61-66.
Liberopoulos E,Siamopoulos K,Elisaf M K .2004 .Apolipoprotein E and renal disease. AJKD, 43(2) : 223-233.
Luc G,Bard JM,Arveiler D,Evans A,Cambou JP,Bingham A,Cambien F A .1994 .Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler. Thromb. Vasc. Biol, 14(9) : 1412-1419.
Mahley RW .1988 .Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 240(4852) : 622-630.
Mangravite LM,Krauss RM .2007 .Pharmacogenomics of statin response. Curr. Opin. Lipidol., 18(4) : 409-414.
Mangravite LM,Thorn CF,Krauss RM .2006 .Clinical implications of pharmacogenomics of statin treatment. Pharmacogenomics, 6(6) : 360-374.
Neiminen T,Kahonen M,Viiri LE,Gronroos P,Lehtimaki T .2008 .Pharmacogenetics of apoliproprotein E gene during lipid-lowering therapy: Lipid levels and prevention of coronary heart disease. Pharmacogenomics, 9(10) : 1475-1486.
Pena R,Lahoz C,Mostaza JM,Jimenez J,Subirats E,Pinto X .2002 .Effect of apoE genotype on the hypolipidaemic response to pravastatin in an outpatient setting. J. Intern. Med, 251(6) : 518-525.
Peters BJ,Pett H,Klungel OH,Stricker BHC,Psaty BM,Glazer NL,Maitland-van der Zee AH .2011 .Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI. , 217(2) : 458-464.
Poduri A,Khullar M,Bahl A,Sehrawat BS,Sharma Y,Talwar KK Y .2010 .Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4 and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy. DNA Cell Biol, 29(10) : 629-637.
Polisecki E,Muallem H,Maeda N,Peter I,Robertson M,McMahon AD .2008 .Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER. , 200(1) : 109-114.
Postmus I,Verschuren JJ,De Craen AJ,Slagboom PE,Westendorp RG,Jukema JW,Trompet S JW .2012 .Pharmacogenetics of statins: Achievements, wholegenome analyses and future perspectives. Pharmacogenomics, 13(7) : 831-840.
Radovica I,Fridmanis D,Silamikelis I,Nikitina-Zake L,Klovins J .2014 .Association between CETP, MLXIPL and TOMM40 polymorphisms and serum lipid levels in a Latvian population. Meta Gene, 2 : 565-578.
Saidi S,Slamia LB,Ammou SB,Mahjoub T,Almawi WY .2007 .Association of apolipoprotein E gene polymorphism with ischemic stroke involving largevessel disease and its relation to serum lipid levels. J. Stroke Cerebrovasc. Dis., 16(4) : 160-166.
Sanllehy C,Casals E,Rodriguez-Villar C,Zambón D,Ojuel J,Ballesta AM,Ros E .1998 .Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia. Metabolism, 47(5) : 560-565.
.2009 .HardyWeinberg equilibrium calculator including analysis for ascertainment bias. Am. J. Epidemiol. Advance Access, 169(4) : 505-514.
Sarzynski MA,Jacobson P,Rankinen T,Carlsson B,Sjöström L,Carlsson LM,Bouchard C .2011 .Association of GWAS-based candidate genes with HDL-cholesterol levels before and after bariatric surgery in the Swedish obese subjects study. J. Clin. Endocrinol. Metab., 96(6) : E953-E957.
Langmann Schmitz G,T Schmitz G .2006 .Pharmacogenomics of cholesterol-lowering therapy. Curr. Vasc. Pharmacol., 44(2) : 75-89.
Shanmugasundaram M,Rough SJ,Alpert JS .2010 .Dyslipidemia in the elderly: Should it be treated? Clin. , 33(1) : 4-9.
Teslovich TM,Musunuru K,Smith AV,Edmondson AC,Stylianou IM,Koseki M,Dominiczak AF M .2010 .Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466(7307) : 707-713.
Thompson JF,Hyde CL,Wood LS,Paciga SA,Hinds DA,Cox DR,Kastelein JJ .2009 .Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort. Circ. Cardiovasc. Genet, 2(2) : 173-181.
Thompson JF,Man M,Johnson KJ,Wood LS,Lira ME,Lloyd DB,Sasiela WJ .2005 .An association study of 43 SNPs in 16 candidate genes with atorvastatin response. Pharmacogenomics J., 5(6) : 352-358.
Utermann G .1987 .Apolipoprotein E polymorphism in health and disease. Am. Heart J., 113(2) : 433-440.
Voora D,Shah SH,Reed CR,Zhai J,Crosslin DR,Messer C,Ginsburg GS C .2008 .Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response. Circ. Cardiovasc. Genet, 1(2) : 100-106.
Wallace C,Newhouse SJ,Braund P,Zhang F,Tobin M,Falchi M,Wellcome Trust Case Control Consortium M .2008 .Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am. J. Hum. Genet, 82(1) : 139-149.
Willer CJ,Sanna S,Jackson AU,Scuteri A,Bonnycastle LL,Clarke R,Abecasis GR .2008 .Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet, 40(2) : 161-169.
Yamauchi K,Tozuka M,Nakabayashi T,Sugano M,Hidaka H,Kondo Y,Katsuyama T Y .1999 .Apolipoprotein E in cerebrospinal fluid: Relation to phenotype and plasma apolipoprotein E concentrations. Clin. Chem, 45(4) : 497-504.
Zintzaras E,Kitsios GD,Triposkiadis F,Lau J,Raman G .2009 .APOE gene polymorphisms and response to statin therapy. Pharmacogenomics J., 9(4) : 248-257.